HEADER SIGNALING PROTEIN 02-OCT-98 1EBA TITLE COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) TITLE 2 RECEPTOR [EBP] AND AN INACTIVE PEPTIDE [EMP33] CONTAINS 3,5- TITLE 3 DIBROMOTYROSINE IN POSITION 4 (DENOTED DBY) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (ERYTHROPOIETIN RECEPTOR); COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 5 SYNONYM: EBP, EPO-R; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PROTEIN (EPO MIMETICS PEPTIDE 33); COMPND 9 CHAIN: C, D; COMPND 10 SYNONYM: EMP33,; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES KEYWDS ERYTHROPOIETIN RECEPTOR, SIGNAL TRANSDUCTION, PROTEIN MINIMIZATION, KEYWDS 2 DRUG DESIGN, CYTOKINE RECEPTOR CLASS 1, COMPLEX (CYTOKINE RECEPTOR- KEYWDS 3 PEPTIDE), SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR O.LIVNAH,E.A.STURA,I.A.WILSON REVDAT 6 09-AUG-23 1EBA 1 LINK REVDAT 5 24-FEB-09 1EBA 1 VERSN REVDAT 4 01-APR-03 1EBA 1 JRNL REVDAT 3 29-DEC-99 1EBA 4 HEADER COMPND REMARK JRNL REVDAT 3 2 4 ATOM SOURCE SEQRES REVDAT 2 18-NOV-98 1EBA 3 HET REMARK HETATM SEQRES REVDAT 2 2 3 DBREF SEQADV FORMUL CRYST1 REVDAT 2 3 3 JRNL CONECT LINK REVDAT 1 11-NOV-98 1EBA 0 JRNL AUTH O.LIVNAH,D.L.JOHNSON,E.A.STURA,F.X.FARRELL,F.P.BARBONE, JRNL AUTH 2 Y.YOU,K.D.LIU,M.A.GOLDSMITH,W.HE,C.D.KRAUSE,S.PESTKA, JRNL AUTH 3 L.K.JOLLIFFE,I.A.WILSON JRNL TITL AN ANTAGONIST PEPTIDE-EPO RECEPTOR COMPLEX SUGGESTS THAT JRNL TITL 2 RECEPTOR DIMERIZATION IS NOT SUFFICIENT FOR ACTIVATION. JRNL REF NAT.STRUCT.BIOL. V. 5 993 1998 JRNL REFN ISSN 1072-8368 JRNL PMID 9808045 JRNL DOI 10.1038/2965 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH O.LIVNAH,E.A.STURA,D.L.JOHNSON,S.A.MIDDLETON,L.S.MULCAHY, REMARK 1 AUTH 2 N.C.WRIGHTON,W.J.DOWER,L.K.JOLLIFFE,I.A.WILSON REMARK 1 TITL FUNCTIONAL MIMICRY OF A PROTEIN HORMONE BY A PEPTIDE REMARK 1 TITL 2 AGONIST: THE EPO RECEPTOR COMPLEX AT 2.8 A REMARK 1 REF SCIENCE V. 273 464 1996 REMARK 1 REFN ISSN 0036-8075 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.8 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 16100 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.299 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3536 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.550 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1EBA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB. REMARK 100 THE DEPOSITION ID IS D_1000008252. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 99999 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08900 REMARK 200 FOR THE DATA SET : 19.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.30000 REMARK 200 FOR SHELL : 4.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE (CCP4), CCP4 REMARK 200 STARTING MODEL: 1EBP MONOMER REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.50450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.26350 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.50450 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 65.26350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 -1.000000 0.000000 0.000000 58.89000 REMARK 350 BIOMT2 1 0.000000 -1.000000 0.000000 37.50450 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 -65.26350 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C, D REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 -1.000000 0.000000 0.000000 58.89000 REMARK 350 BIOMT2 1 0.000000 -1.000000 0.000000 37.50450 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 65.26350 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 164 REMARK 465 GLY A 165 REMARK 465 ALA A 166 REMARK 465 ASP B 133 REMARK 465 GLU B 134 REMARK 465 ALA B 166 REMARK 465 GLY B 167 REMARK 465 PRO B 221 REMARK 465 SER B 222 REMARK 465 ASP B 223 REMARK 465 LEU B 224 REMARK 465 GLY C 1 REMARK 465 GLY C 2 REMARK 465 GLY C 19 REMARK 465 GLY C 20 REMARK 465 GLY D 1 REMARK 465 GLY D 2 REMARK 465 GLY D 19 REMARK 465 GLY D 20 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 32 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 19 -179.09 -52.90 REMARK 500 LEU A 33 35.98 -71.83 REMARK 500 GLU A 34 27.47 -143.36 REMARK 500 SER A 45 104.53 179.23 REMARK 500 ASP A 61 -7.97 77.08 REMARK 500 GLU A 134 -91.22 -85.95 REMARK 500 HIS A 137 172.24 -58.94 REMARK 500 SER A 152 0.28 -65.67 REMARK 500 ALA B 19 123.63 -27.29 REMARK 500 ARG B 21 -169.73 -73.12 REMARK 500 GLU B 31 -61.57 -93.67 REMARK 500 GLU B 34 51.13 -148.65 REMARK 500 THR B 90 45.94 -83.08 REMARK 500 SER B 92 -81.71 -60.86 REMARK 500 LEU B 121 173.93 -59.76 REMARK 500 ASN B 164 84.69 46.35 REMARK 500 GLN B 170 138.46 -177.96 REMARK 500 THR B 179 50.75 -107.80 REMARK 500 SER B 184 -99.05 -106.60 REMARK 500 ASN B 185 97.64 -48.06 REMARK 500 GLU B 202 174.74 -59.92 REMARK 500 TRP C 13 146.28 -39.62 REMARK 500 PRO D 10 -71.21 -37.79 REMARK 500 REMARK 500 REMARK: NULL DBREF 1EBA A 10 224 UNP P19235 EPOR_HUMAN 34 248 DBREF 1EBA B 10 224 UNP P19235 EPOR_HUMAN 34 248 DBREF 1EBA C 1 20 PDB 1EBA 1EBA 1 20 DBREF 1EBA D 1 20 PDB 1EBA 1EBA 1 20 SEQRES 1 A 215 LYS PHE GLU SER LYS ALA ALA LEU LEU ALA ALA ARG GLY SEQRES 2 A 215 PRO GLU GLU LEU LEU CYS PHE THR GLU ARG LEU GLU ASP SEQRES 3 A 215 LEU VAL CYS PHE TRP GLU GLU ALA ALA SER ALA GLY VAL SEQRES 4 A 215 GLY PRO GLY ASN TYR SER PHE SER TYR GLN LEU GLU ASP SEQRES 5 A 215 GLU PRO TRP LYS LEU CYS ARG LEU HIS GLN ALA PRO THR SEQRES 6 A 215 ALA ARG GLY ALA VAL ARG PHE TRP CYS SER LEU PRO THR SEQRES 7 A 215 ALA ASP THR SER SER PHE VAL PRO LEU GLU LEU ARG VAL SEQRES 8 A 215 THR ALA ALA SER GLY ALA PRO ARG TYR HIS ARG VAL ILE SEQRES 9 A 215 HIS ILE ASN GLU VAL VAL LEU LEU ASP ALA PRO VAL GLY SEQRES 10 A 215 LEU VAL ALA ARG LEU ALA ASP GLU SER GLY HIS VAL VAL SEQRES 11 A 215 LEU ARG TRP LEU PRO PRO PRO GLU THR PRO MET THR SER SEQRES 12 A 215 HIS ILE ARG TYR GLU VAL ASP VAL SER ALA GLY ASN GLY SEQRES 13 A 215 ALA GLY SER VAL GLN ARG VAL GLU ILE LEU GLU GLY ARG SEQRES 14 A 215 THR GLU CYS VAL LEU SER ASN LEU ARG GLY ARG THR ARG SEQRES 15 A 215 TYR THR PHE ALA VAL ARG ALA ARG MET ALA GLU PRO SER SEQRES 16 A 215 PHE GLY GLY PHE TRP SER ALA TRP SER GLU PRO VAL SER SEQRES 17 A 215 LEU LEU THR PRO SER ASP LEU SEQRES 1 B 215 LYS PHE GLU SER LYS ALA ALA LEU LEU ALA ALA ARG GLY SEQRES 2 B 215 PRO GLU GLU LEU LEU CYS PHE THR GLU ARG LEU GLU ASP SEQRES 3 B 215 LEU VAL CYS PHE TRP GLU GLU ALA ALA SER ALA GLY VAL SEQRES 4 B 215 GLY PRO GLY ASN TYR SER PHE SER TYR GLN LEU GLU ASP SEQRES 5 B 215 GLU PRO TRP LYS LEU CYS ARG LEU HIS GLN ALA PRO THR SEQRES 6 B 215 ALA ARG GLY ALA VAL ARG PHE TRP CYS SER LEU PRO THR SEQRES 7 B 215 ALA ASP THR SER SER PHE VAL PRO LEU GLU LEU ARG VAL SEQRES 8 B 215 THR ALA ALA SER GLY ALA PRO ARG TYR HIS ARG VAL ILE SEQRES 9 B 215 HIS ILE ASN GLU VAL VAL LEU LEU ASP ALA PRO VAL GLY SEQRES 10 B 215 LEU VAL ALA ARG LEU ALA ASP GLU SER GLY HIS VAL VAL SEQRES 11 B 215 LEU ARG TRP LEU PRO PRO PRO GLU THR PRO MET THR SER SEQRES 12 B 215 HIS ILE ARG TYR GLU VAL ASP VAL SER ALA GLY ASN GLY SEQRES 13 B 215 ALA GLY SER VAL GLN ARG VAL GLU ILE LEU GLU GLY ARG SEQRES 14 B 215 THR GLU CYS VAL LEU SER ASN LEU ARG GLY ARG THR ARG SEQRES 15 B 215 TYR THR PHE ALA VAL ARG ALA ARG MET ALA GLU PRO SER SEQRES 16 B 215 PHE GLY GLY PHE TRP SER ALA TRP SER GLU PRO VAL SER SEQRES 17 B 215 LEU LEU THR PRO SER ASP LEU SEQRES 1 C 20 GLY GLY THR DBY SER CYS HIS PHE GLY PRO LEU THR TRP SEQRES 2 C 20 VAL CYS LYS PRO GLN GLY GLY SEQRES 1 D 20 GLY GLY THR DBY SER CYS HIS PHE GLY PRO LEU THR TRP SEQRES 2 D 20 VAL CYS LYS PRO GLN GLY GLY MODRES 1EBA DBY C 4 TYR 3,5 DIBROMOTYROSINE MODRES 1EBA DBY D 4 TYR 3,5 DIBROMOTYROSINE HET DBY C 4 14 HET DBY D 4 14 HETNAM DBY 3,5 DIBROMOTYROSINE FORMUL 3 DBY 2(C9 H9 BR2 N O3) HELIX 1 1 PHE A 11 LEU A 18 1 8 HELIX 2 2 PRO A 50 ASN A 52 5 3 HELIX 3 3 THR A 87 ASP A 89 5 3 HELIX 4 4 ILE A 115 GLU A 117 5 3 HELIX 5 5 THR A 151 HIS A 153 5 3 HELIX 6 6 PHE B 11 LEU B 18 1 8 HELIX 7 7 PRO B 50 ASN B 52 5 3 HELIX 8 8 THR B 87 ASP B 89 5 3 HELIX 9 9 ILE B 115 GLU B 117 5 3 HELIX 10 10 THR B 151 HIS B 153 5 3 SHEET 1 A 4 LEU A 27 PHE A 29 0 SHEET 2 A 4 VAL A 37 GLU A 42 -1 N PHE A 39 O LEU A 27 SHEET 3 A 4 VAL A 79 SER A 84 -1 N CYS A 83 O CYS A 38 SHEET 4 A 4 HIS A 70 PRO A 73 -1 N ALA A 72 O ARG A 80 SHEET 1 B 4 LYS A 65 CYS A 67 0 SHEET 2 B 4 TYR A 53 LEU A 59 -1 N TYR A 57 O LYS A 65 SHEET 3 B 4 LEU A 96 ALA A 102 -1 N THR A 101 O SER A 54 SHEET 4 B 4 PRO A 107 ILE A 113 -1 N ILE A 113 O LEU A 96 SHEET 1 C 3 VAL A 128 LEU A 131 0 SHEET 2 C 3 VAL A 138 ARG A 141 -1 N ARG A 141 O VAL A 128 SHEET 3 C 3 GLU A 180 LEU A 183 -1 N LEU A 183 O VAL A 138 SHEET 1 D 4 ARG A 171 ILE A 174 0 SHEET 2 D 4 ILE A 154 ALA A 162 -1 N VAL A 158 O VAL A 172 SHEET 3 D 4 ARG A 191 MET A 200 -1 N ARG A 199 O ARG A 155 SHEET 4 D 4 VAL A 216 LEU A 219 -1 N LEU A 218 O TYR A 192 SHEET 1 E 3 LEU B 27 PHE B 29 0 SHEET 2 E 3 VAL B 37 GLU B 42 -1 N PHE B 39 O LEU B 27 SHEET 3 E 3 VAL B 79 SER B 84 -1 N CYS B 83 O CYS B 38 SHEET 1 F 3 TYR B 53 LEU B 59 0 SHEET 2 F 3 LEU B 96 ALA B 102 -1 N THR B 101 O SER B 54 SHEET 3 F 3 PRO B 107 ILE B 113 -1 N ILE B 113 O LEU B 96 SHEET 1 G 3 VAL B 128 LEU B 131 0 SHEET 2 G 3 VAL B 138 ARG B 141 -1 N ARG B 141 O VAL B 128 SHEET 3 G 3 GLU B 180 LEU B 183 -1 N LEU B 183 O VAL B 138 SHEET 1 H 4 GLN B 170 ILE B 174 0 SHEET 2 H 4 ILE B 154 ALA B 162 -1 N VAL B 160 O GLN B 170 SHEET 3 H 4 ARG B 191 MET B 200 -1 N ARG B 199 O ARG B 155 SHEET 4 H 4 VAL B 216 LEU B 219 -1 N LEU B 218 O TYR B 192 SSBOND 1 CYS A 28 CYS A 38 1555 1555 2.02 SSBOND 2 CYS A 67 CYS A 83 1555 1555 2.02 SSBOND 3 CYS B 28 CYS B 38 1555 1555 2.03 SSBOND 4 CYS B 67 CYS B 83 1555 1555 2.02 SSBOND 5 CYS C 6 CYS C 15 1555 1555 2.02 SSBOND 6 CYS D 6 CYS D 15 1555 1555 2.03 LINK C THR C 3 N DBY C 4 1555 1555 1.33 LINK C DBY C 4 N SER C 5 1555 1555 1.33 LINK C THR D 3 N DBY D 4 1555 1555 1.33 LINK C DBY D 4 N SER D 5 1555 1555 1.33 CISPEP 1 GLU A 202 PRO A 203 0 -0.15 CISPEP 2 GLU B 202 PRO B 203 0 0.36 CRYST1 58.890 75.009 130.527 90.00 90.00 90.00 P 2 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016981 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013332 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007661 0.00000